Get started
Biotest AGBiotest AGBiotest AG

Biotest AG

No trades
OverviewFinancialsCommunitySeasonals

Chart


Full chart

Key stats


Market capitalization
‪1.62 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪28.56 M‬ USD
Revenue (FY)
‪785.52 M‬ USD
Shares float
—
Beta (1Y)
−0.04

About Biotest AG


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Jörg Schüttrumpf
Website
biotest.de
Headquarters
Dreieich
Founded
1946
IPO date
Oct 14, 1987
Identifiers
3
ISIN US0906731049
Biotest AG engages in the development, manufacture, and marketing of plasma proteins and biotherapeutic drugs that used to treat serious and life-threatening conditions. The company was founded by Carl Adolf Schleussner and Hans Schleussner in 1946 and is headquartered in Dreieich, Germany.

Check out other big names from the same industry as BTTAY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.